Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04406935 · ClinicalTrials.gov registry record · NA
Evaluation of the Safety and Efficacy of the NuEra Tight for Abdominal Circumference Reduction
A NA study, sponsored by Lumenis Be.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT04406935: Completed NA study, sponsored by Lumenis Be.
NCT04406935 is a NA study that has completed, run by Lumenis Be. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04406935, a NA study, has completed, sponsored by Lumenis Be.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Clinical study to evaluate the safety and efficacy of the NuEra Tight for circumferential reduction in the abdominal region within three treatment group
Primary Outcome
Change in abdominal circumference in cm
Interventions
- DEVICE treatment with the study device (NuEra)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2019-12-02 |
| Est. Completion | 2021-11-30 |
| Phase | NA |
What the finished NCT04406935 record still lists
NCT04406935 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which treatment with the study device (NuEra) is the first listed.
NCT04406935 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04406935 about?
NCT04406935 is a clinical study titled "Evaluation of the Safety and Efficacy of the NuEra Tight for Abdominal Circumference Reduction". Clinical study to evaluate the safety and efficacy of the NuEra Tight for circumferential reduction in the abdominal region within three treatment group
What is the current status of trial NCT04406935?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2019-12-02. Estimated completion is 2021-11-30.
What interventions are being tested in trial NCT04406935?
The interventions under investigation include: treatment with the study device (NuEra) (DEVICE).
Who is sponsoring clinical trial NCT04406935?
This trial is sponsored by Lumenis Be, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04406935's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI